Microparticles, Vector of Genetic Information During HIV Infection

Microparticles, Vector of Genetic Information During HIV Infection ?

The aim of the investigators study is to demonstrate in healthy subjects and a cohort of patients infected with HIV, the presence of miRNAs in circulating peripheral blood microparticles (MPs).

Inclusion Criteria:

• Age of 40 +/-10 years
• Seronegativity for the HIV 2
• Patients of the group A: seropositivity for the HIV 1 confirmed in ELISA and Western Blot for at least 2 years and having never received from antiretroviral treatment, with a viral plasmatique load > 1000 copies / ml
• Patients of the group B: seropositivity for the HIV 1 confirmed in ELISA and Western Blot for at least 2 years and under stable antiretroviral treatment for at least 6 months, with a viral load undetectable plasmatique (< 40 copies / ml)
• patients of the group C : Matching on the age (+/-3 years) to a patient
• Be considered healthy by the Investigator after a clinical examination Seronegativity for the HIV 1 confirmed in ELISA the day of the taking

Exclusion Criteria:

group A et B

• Age of < 30 years and > in 50 years
• Seropositivity for the HIV 2

group C Seropositivity for the HIV 2

- Be under medicinal treatment